It inhibits the aggregation of leukocytes, reduces the formation of bradykinin, inhibits platelet agglutination, and induces apoptosis and anti-angiogenesis by selectively inhibiting the activity of COX-2, thus producing antipyretic, analgesic, anti-inflammatory, and anti-cancer effects (Kaduševičius, 2021). Here, PTGS2 is linked to cancer.